.png)

Founders rarely think about the convertible notes they signed at seed by the time they are preparing a Series B. The notes are sitting in a data room folder. The business has grown. The problem feels like ancient history.
It is not. When a Series B lead investor opens your cap table, those uncapped notes are one of the first things they model. As part of the broader cap table risk cluster, uncapped note overhang is a structural issue, not a legacy paperwork detail. It changes the ownership math before terms are proposed, and institutional investors treat unresolved dilution uncertainty as a signal about cap table discipline across the entire company.
A convertible note is debt that converts into equity at a future priced round. Most seed-stage notes include two protective terms for investors: a valuation cap and a discount rate. The investor converts at whichever produces the lower price per share, giving them more equity for their money.
The cap sets a ceiling. It says: no matter how high the Series B valuation goes, the note converts as if the company were worth no more than X. That ceiling protects the noteholder's return and, critically, makes the dilution math predictable for founders and incoming investors.
An uncapped note removes that ceiling entirely.
The discount still applies to an uncapped note. But without a cap, the conversion price drops in proportion to the round price. A 20% discount at a $200M Series B valuation produces a very different share count than the same discount at a $60M Series A. The noteholder benefits more as the company's valuation grows. The founder absorbs that benefit in the form of dilution they cannot fully predict until the round price is set.
That is the core mechanics problem. The investor diligence problem is different, and it is more serious.
A Series B lead is not reviewing your cap table to understand the history. They are stress-testing the post-money ownership stack to see whether the deal works after everything converts, the option pool gets refreshed, and new money comes in.
Uncapped notes make that test harder. According to Carta's convertible note modeling guidance, a proper note conversion model requires the principal amount, assumed accrued interest, the discount rate, the priced round assumptions, and the option pool size - all at once. When any of those inputs is uncertain, the ownership output is uncertain. Uncapped notes add a layer of uncertainty that capped notes do not: the final share count cannot be confirmed until the round price is locked.
Here is what an institutional lead investor is actually working through when they see uncapped notes on your cap table:
None of these questions are unanswerable. But uncapped notes force the investor to model multiple scenarios before they can answer any of them. That extra modeling step signals cap table complexity. And in competitive deal environments, complexity that the investor has to resolve - rather than complexity the founder has already resolved - slows engagement or stops it.
Here is a simplified example to make the open-ended dilution concrete.
A founder raised $1.5M in seed capital via an uncapped convertible note with a 20% discount and 6% annual interest. The note has been outstanding for two years. By the time the Series B closes, the total obligation including accrued interest is approximately $1.68M.
The Series B closes at a $150M pre-money valuation on 10 million fully diluted shares, giving a share price of $15.00. The note converts at a 20% discount, so the effective conversion price is $12.00 per share.
The key insight: the share count changes with every scenario. At a lower valuation, the note converts into more shares. At a higher valuation, it converts into fewer. There is no fixed ceiling telling the founder or the lead investor exactly what the noteholder will own until the round price is set.
That uncertainty is what IRC Partners' Cap Table Forensics process routinely surfaces: founders often own 5-15% less than expected once prior convertibles are fully modeled across realistic round scenarios. The gap is not always dramatic. But when a Series B lead is trying to confirm that founders still own enough to stay motivated after the round, even a 2-3% variance in noteholder ownership can change the deal structure conversation.
The real problem is not the discount itself. Most institutional investors expect some discount on seed-stage risk capital. The problem is that without a cap, the dilution outcome is tied to a future round price the founder does not control at the time the note is signed.
Uncapped note conversion rarely sits in isolation. It interacts with every other instrument on the cap table, and those interactions are what institutional investors are really stress-testing.
Four spillover effects that compound the problem:
The investor's concern is not just the math. It is what the math says about how the company was built.
The goal is simple: model the note conversion before the investor does. If you find a problem, fix it or disclose it with context. If the math works, present it cleanly so the investor does not have to build the model from scratch.
Pre-Series B note overhang checklist:
The Capital Stack Explained guide on IRC Partners covers how stacked convertibles interact with later institutional rounds in more detail.
Founders who complete this prep keep the Series B conversation focused on the business. Founders who skip it hand the investor a modeling problem to solve before they can engage on terms. For a broader look at what else kills institutional raises before terms are discussed, the 10 mistakes that kill your first institutional raise is worth reading alongside this checklist.
A capped convertible note converts at the lower of a fixed maximum valuation or the discounted round price. The cap creates a predictable ceiling on dilution. An uncapped note has no ceiling, so the conversion price is calculated purely as a percentage discount off the Series B share price. The higher the Series B valuation, the more favorable the discount becomes for the noteholder and the less predictable the dilution is for founders and incoming investors.
No. Uncapped notes are a diligence red flag because they introduce dilution uncertainty, not because they make a deal impossible. A founder who has modeled the conversion scenarios, confirmed that founder ownership remains viable post-close, and can present a clean fully diluted cap table will face far less friction than one who has not done that work. The issue is unresolved uncertainty, not the instrument itself.
Accrued interest increases the total principal converting into equity. On a $1.5M note at 6% annual interest outstanding for three years, the conversion amount is approximately $1.77M rather than $1.5M. That 18% increase in conversion principal translates directly into additional shares issued to the noteholder. Founders who model only the original principal underestimate dilution by the full interest accrual, which can be material on larger notes or long-outstanding instruments.
Because the seed-stage terms affect the post-money cap table they are buying into. A Series B lead investor is acquiring a stake in a company that already has legacy obligations. If those obligations convert in a way that compresses founder ownership below alignment thresholds or reduces the room available for the lead's target stake, the investor either reprices the deal or walks away. The origin of the note is irrelevant. The impact on the cap table at close is what matters.
Yes, in principle. Noteholders can agree to add a valuation cap or modify conversion terms before a priced round. In practice, noteholders who hold uncapped notes benefit from the open-ended discount as valuations rise, so they have limited incentive to accept a cap unless offered something in return. Founders considering renegotiation should do so early, before the Series B process starts, and with counsel. Attempting to modify note terms mid-process creates additional diligence complexity.
Most institutional Series B leads expect combined founder ownership of at least 20-30% post-money on a fully diluted basis, though thresholds vary by fund and deal structure. Below 15-20%, investors begin to question whether founders are sufficiently incentivized to drive the growth the round is designed to fund. Uncapped note conversion that pushes founders below that threshold, especially when combined with option pool refreshes, is one of the scenarios that causes a lead to restructure or reduce the round size.
At least six months before beginning outbound fundraising. That timeline gives founders room to model conversion scenarios, identify any cap table issues, engage noteholders about modifications if needed, and update the cap table software so the fully diluted view is accurate before the first investor data room is opened. Founders who start this process after receiving investor interest are already behind.
Most founders don't lose the raise because of the pitch. They lose it because the structure was wrong before the first investor call.IRC Partners advises founders raising $5M to $250M of institutional capital. 7 strategic partners per quarter. Start here to schedule a call with our team.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.